Status:
COMPLETED
The Effect of Mastiha Oil in Metabolic Syndrome
Lead Sponsor:
Harokopio University
Conditions:
Metabolic Syndrome
Eligibility:
All Genders
30-75 years
Phase:
NA
Brief Summary
Mastiha Oil is a 100% natural product of the Mediterranean, extracted from the resin of Mastiha. Over 90 compounds have been identified in Mastiha oil, with monoterpenes exhibiting favorable effects i...
Eligibility Criteria
Inclusion
- 30 years \< Age \< 75 years
- Metabolic Syndrome cardiometabolic parameters
- A stable weight for ≥ 3 months pre-intervention
- An unchanged treatment regimen for ≥ 6 months pre-intervention
Exclusion
- Hepatotoxic Medication
- Untreated Diabetes Mellitus
- Dysthyroidism, hypopituitarism, Cushing syndrome / disease
- Pregnancy, lactation
- Psychiatric or mental disorder
- Any use of antioxidant-phytochemical rich supplement, vitamin D supplement, anti-, pre- or pro-biotics within 3 months pre-intervention
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 28 2023
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT04785573
Start Date
March 1 2021
End Date
March 28 2023
Last Update
April 25 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Harokopio University
Athens, Attica, Greece, 17671
2
Andriana Kaliora
Athens, Greece, 17671